Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Assets (2017 - 2025)

Anaptysbio filings provide 9 years of Return on Assets readings, the most recent being 0.0% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 30.0% year-over-year to 0.0%, compared with a TTM value of 0.0% through Dec 2025, up 30.0%, and an annual FY2025 reading of 0.0%, up 31.0% over the prior year.
  • Return on Assets hit 0.0% in Q4 2025 for Anaptysbio, up from 0.25% in the prior quarter.
  • The five-year high for Return on Assets was 0.02% in Q3 2021, with the low at 0.35% in Q2 2025.
  • Median Return on Assets over the past 5 years was 0.13% (2022), compared with a mean of 0.14%.
  • The largest YoY upside for Return on Assets was 30bps in 2025 against a maximum downside of -33bps in 2025.
  • Year by year, Return on Assets stood at 0.11% in 2021, then tumbled by -66bps to 0.18% in 2022, then skyrocketed by 105bps to 0.01% in 2023, then tumbled by -3350bps to 0.3% in 2024, then surged by 100bps to 0.0% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.0%, 0.25%, and 0.35% for Q4 2025, Q3 2025, and Q2 2025 respectively.